Intrinsic Value of S&P & Nasdaq Contact Us

Tharimmune, Inc. THAR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
26/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — THAR

Tharimmune, Inc. (THAR) has a market capitalization of $134.01M and trades at $3.39. The 52-week range is 0.952-9.08.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3, Earnings Per Share (EPS) of $-1.12.

The stock has a beta of 1.45, operates in the Healthcare sector.

Trading Data
Current Price$3.39
52-Week Range0.952-9.08
Volume900.66K
Avg Volume (30D)807.86K
Market Cap$134.01M
Beta (1Y)1.45
Company
IPO Date2022-01-12
Employees2
CEOMark Wendland
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS4327053090
CUSIP432705200
Income (Latest Year)
EBITDA$-42.08M
Operating Income$-20.11M
Net Income$-35.92M
EPS$-1.12
EPS Diluted$-1.12
Shares Outstanding$32.05M
Balance Sheet (Latest Year)
Total Assets$519.15M
Current Assets$17.39M
Cash & ST Investments$17.03M
Total Liabilities$121.22M
Net Debt$-17.03M
Total Equity$397.93M
Valuation Ratios
P/E Ratio-3
P/B Ratio0.34
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message